Assessment of the ß-alanine effect in acute lower and upper extremity ischemia

Assessment of the ß-alanine effect on postoperative clinical outcomes in patients with acute lower and upper extremity ischemia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210919052515N5

Enrollment

Registered

2022-05-04

Start date

2022-05-22

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute extremity ischemia. Acute lower limb arterial occlusion

Interventions

Intervention 1: Intervention group: Patients in the intervention group will be received 4 gr of oral ß-alanine before surgery and 4 hours after surgery. The routine treatment of patients is receiving

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acute extremity ischemia patients Having surgical indications and the possibility of limb preservation

Exclusion criteria

Exclusion criteria: Gangrene of the limbs Motlelling of the limbs Amputation Indication Renal failure diseases

Design outcomes

Primary

Measure	Time frame
Loss of limbs. Timepoint: After the intervention at hospitalization. Method of measurement: Clinical examination.	—

Secondary

Measure	Time frame
Complications. Timepoint: After the intervention at hospitalization. Method of measurement: Clinical examination.;Mortality. Timepoint: After the intervention at hospitalization. Method of measurement: Yes/no.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Naser Masoudi

Oroumia University of Medical Sciences

masoudi.n@umsu.ac.ir+98 44 3345 7286

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026